Characterization and treatment of local recurrence following breast conservation for ductal carcinoma in situ
- PMID: 24859938
- PMCID: PMC4539255
- DOI: 10.1245/s10434-014-3802-7
Characterization and treatment of local recurrence following breast conservation for ductal carcinoma in situ
Abstract
Purpose: The optimal treatment strategy for ductal carcinoma in situ (DCIS) continues to evolve and should consider the consequences of initial treatment on the likelihood, type, and treatment of recurrences.
Methods: We conducted a retrospective cohort study using two data sources of patients who experienced a recurrence (DCIS or invasive cancer) following breast-conserving surgery (BCS) for index DCIS: patients with an index DCIS diagnosed from 1997 to 2008 at the academic institutions of the National Comprehensive Cancer Network (NCCN; N = 88) and patients with an index DCIS diagnosed from 1990 to 2001 at community-based integrated healthcare delivery sites of the Health Maintenance Organization Cancer Research Network (CRN) (N = 182).
Results: Just under half of local recurrences in both cohorts were invasive cancer. While 40 % of patients in both cohorts underwent mastectomy alone at recurrence, treatment of the remaining patients varied. In the earlier CRN cohort, most other patients underwent repeat BCS (39 %) with only 18 % receiving mastectomy with reconstruction, whereas only 16 % had repeat BCS and 44 % had mastectomy with reconstruction in the NCCN cohort. Compared with patients not treated with radiation, those who received radiation for index DCIS were less likely to undergo repeat BCS (NCCN: 6.6 vs. 37 %, p = 0.001; CRN: 20 vs. 48 %, p = 0.0004) and more likely to experience surgical complications after treatment of recurrence (NCCN: 15 vs. 4 %, p = 0.17; CRN: 40 vs. 25 %, p = 0.09).
Conclusion: We found that treatment of recurrences after BCS and subsequent complications may be affected by the use of radiotherapy for the index DCIS. Initial treatment of DCIS may have long-term implications that should be considered.
Conflict of interest statement
Figures


Similar articles
-
Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.World J Surg Oncol. 2016 Apr 27;14:126. doi: 10.1186/s12957-016-0885-6. World J Surg Oncol. 2016. PMID: 27122132 Free PMC article.
-
Association of Regional Intensity of Ductal Carcinoma In Situ Treatment With Likelihood of Breast Preservation.JAMA Oncol. 2017 Jan 1;3(1):101-104. doi: 10.1001/jamaoncol.2016.2164. JAMA Oncol. 2017. PMID: 27442038
-
Patterns of invasive recurrence among patients originally treated for ductal carcinoma in situ by breast-conserving surgery versus mastectomy.Breast Cancer Res Treat. 2021 Apr;186(3):617-624. doi: 10.1007/s10549-021-06129-3. Epub 2021 Mar 6. Breast Cancer Res Treat. 2021. PMID: 33675490 Free PMC article. Review.
-
Decreasing Recurrence Rates for Ductal Carcinoma In Situ: Analysis of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years.Ann Surg Oncol. 2015 Oct;22(10):3273-81. doi: 10.1245/s10434-015-4740-8. Epub 2015 Jul 28. Ann Surg Oncol. 2015. PMID: 26215193 Free PMC article.
-
A retrospective alternative for active surveillance trials for ductal carcinoma in situ of the breast.Int J Cancer. 2020 Mar 1;146(5):1189-1197. doi: 10.1002/ijc.32362. Epub 2019 May 8. Int J Cancer. 2020. PMID: 31018242 Free PMC article. Review.
Cited by
-
Identification of high- and low-risk groups for ipsilateral recurrence within 10 years after breast-conserving surgery for ductal carcinoma in situ and personalized treatment: a retrospective study.Gland Surg. 2025 Jul 31;14(7):1213-1229. doi: 10.21037/gs-2025-100. Epub 2025 Jul 28. Gland Surg. 2025. PMID: 40771374 Free PMC article.
-
Factors associated with ductal carcinoma in situ (DCIS) treatment patterns and patient-reported outcomes across a large integrated health network.Breast Cancer Res Treat. 2023 Feb;197(3):683-692. doi: 10.1007/s10549-022-06831-w. Epub 2022 Dec 17. Breast Cancer Res Treat. 2023. PMID: 36526807 Free PMC article.
-
Treatment patterns for ductal carcinoma in situ from 2000-2010 across six integrated health plans.Springerplus. 2015 Jan 17;4:24. doi: 10.1186/s40064-014-0776-7. eCollection 2015. Springerplus. 2015. PMID: 25625043 Free PMC article.
References
-
- Sumner WE, 3rd, Koniaris LG, Snell SE, et al. Results of 23,810 cases of ductal carcinoma-in situ. Ann Surg Oncol. 2007;14:1638–1643. - PubMed
-
- Morrow M, Schmidt R, Cregger B, Hassett C, Cox S. Preoperative evaluation of abnormal mammographic findings to avoid unnecessary breast biopsies. Arch Surg. 1994;129:1091–1096. - PubMed
-
- Alexander HR, Candela FC, Dershaw DD, Kinne DW. Needle-localized mammographic lesions: results and evolving treatment strategy. Arch Surg. 1990;125:1441–1444. - PubMed
-
- Silverstein MJ, Gamagami P, Colburn WJ, et al. Nonpalpable breast lesions: diagnosis with slightly overpenetrated screen-film mammography and hook wire-directed biopsy in 1,014 cases. Radiology. 1989;171:633–638. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous